Kapil Sampat
Ophthalmology · Towson, MDNPI 1790097350
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.9%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. Novartis accounts for 67.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $969 and has fallen 85.0% since, to $145 in 2025. That places this record below the midpoint for ophthalmology clinicians in MD, where the typical reported total is $1,143.
Across 16 payments — averaging $83.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$899
- Alcon$183
- Genentech, Inc.$135
- AbbVie$61
- Regeneron$33
- Carl Zeiss Meditec, Inc.$17
Across 39 payments — averaging $15,311 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$313K
- Bayer$163K
- ANI Pharmaceuticals, Inc.$94K
- Alimera Sciences, Inc.$28K
What the payments were for
- Travel & lodging$55642%
- Food & beverage$75757%
- Gifts$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 8 | $899 |
| Alcon | 2 | $183 |
| Genentech, Inc. | 1 | $135 |
| AbbVie | 3 | $61 |
| Regeneron | 1 | $33 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEOVU$320
- Clareon PanOptix Pro$145
- VABYSMO$135
How this compares
$1,330 in reported general payments places this provider in the 50th percentile of 493 ophthalmology providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 77 | $3,863 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 79 | $1,837 |
| Cyclosporine | 13 | $1,190 |
| Latanoprost | 97 | $897 |
| Ofloxacin | 44 | $628 |
| Brimonidine Tartrate | 41 | $568 |
| Dorzolamide Hcl | 11 | $233 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Towson
- Scott LaborwitTowson$204K
- Sanjay GoelTowson$101K
- Alfred SommerBaltimore$2.9M
- Richard AdlerBaltimore$2.7M
- Peter McDonnellBaltimore$1.4M
- Esen AkpekBaltimore$782K
- Lisa FeulnerBel Air$434K
- Allen HuHagerstown$379K
- Susan BresslerLutherville$341K
- Renee BovelleGlenn Dale$292K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.